Krsnaa Diagnost. (KRSNAA)
Slow GrowerFairStock Score: 37/100 — MIXED
Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹575.3 |
| Market Cap | ₹1,866.2 Cr |
| P/E Ratio | 18.62 |
| ROCE | 12.52% |
| ROE | 9.47% |
| Dividend Yield | 0.35% |
| Profit Growth | -19.13% |
| Debt/Equity | 0.55 |
| Sales Growth | 21.3% |
| Promoter Holding | 27.11% |
| 52-Week Range | ₹515 — ₹894.4 |
| Sector | Healthcare Services |
| Book Value | ₹302.22 |
Strengths
- Debt/Equity ratio of 0.31 indicates conservative leverage and financial stability.
- Book value per share of ₹262.38 provides a tangible asset cushion for downside.
- ROCE at 12.52% is respectable and higher than the 9.47% ROE, suggesting some operational efficiency.
- Latest quarter shows a stable net profit margin of roughly 10% (₹16 Cr profit on ₹159 Cr sales).
Concerns
- Sales growth of -3.47% and profit growth of -23.66% show a shrinking business, not compounding.
- Piotroski F-Score of 3/9 signals severe financial stress and weak operating health.
- Promoter holding of only 27.11% is low, reducing alignment with minority shareholders.
- At P/E of 25.65 and P/B of 2.33, valuation offers no margin of safety for declining earnings.
AI Analysis
Krsnaa Diagnost is not a business that would get me excited. With a market cap of ₹2,061 Cr and a P/E of 25.65, the market is paying a full price for a company whose sales have shrunk by 3.47% and profits are down 23.66%. In the latest quarter, sales were ₹159 Cr and net profit ₹16 Cr, a margin of about 10%. But the trailing P/E suggests investors are assuming a rapid return to growth. I don't see evidence for that. The Piotroski F-Score of 3/9 is a serious red flag, indicating weak operating efficiency and deteriorating fundamentals. Graham would demand a margin of safety; at 2.33 times book with a 9.47% ROE, you are paying a premium for subpar returns. Debt-to-equity of 0.31 is manageable, and ROCE at 12.52% is okay, but not outstanding. Also, promoter holding of 27.11% is low; I like my captains to have a large ownership stake. The dividend yield of 0.43% offers no support. This looks like a slow grower at best, possibly a value trap if performance doesn't improve. I would need to see clear signs of revenue stabilization and an improving F-score before considering a nibble. As Benjamin Graham said, price is what you pay, value is what you get. Here, I'm not convinced value is present.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer